Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ANTIRETROVIRAL TREATMENT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01989910
What this trial is testing

Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

Who this might be right for
HIV-1 Infection
Taipei Veterans General Hospital, Taiwan 107
Post-approval studies (Phase 4)Study completedNCT00700115
What this trial is testing

Kaletra-isentress Treatment Evaluation

Who this might be right for
HIV Infections
Emory University 60
Not applicableStudy completedNCT00000908
What this trial is testing

Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 250
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Large-scale testing (Phase 3)Study completedNCT01309243
What this trial is testing

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 799
Testing effectiveness (Phase 2)Ended earlyNCT00513513
What this trial is testing

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 7
Not applicableEnded earlyNCT00341887
What this trial is testing

Epidemiological Study of HIV in the South African National Defense Force

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 8,676
Post-approval studies (Phase 4)Ended earlyNCT00356616
What this trial is testing

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 24
Post-approval studies (Phase 4)UnknownNCT04903847
What this trial is testing

Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil

Who this might be right for
HivHIV InfectionsHIV Lipodystrophy+4 more
Thomas Benfield 126
Not applicableStudy completedNCT00672932
What this trial is testing

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

Who this might be right for
HIV Infections
University of California, San Francisco 18
Early research (Phase 1)Study completedNCT00099671
What this trial is testing

Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableStudy completedNCT01479634
What this trial is testing

Early HIV Therapy in Patients With High CD4 Cell Counts

Who this might be right for
HIV
University of California, San Francisco 279
Large-scale testing (Phase 3)Active Not RecruitingNCT05631093
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 553
Large-scale testing (Phase 3)WithdrawnNCT01255371
What this trial is testing

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Who this might be right for
HIV
ANRS, Emerging Infectious Diseases
Not applicableStudy completedNCT01225406
What this trial is testing

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

Who this might be right for
This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy
The HIV Netherlands Australia Thailand Research Collaboration 56
Not applicableStudy completedNCT02012621
What this trial is testing

Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy

Who this might be right for
HIV/AIDS
University of Colorado, Denver 807
Post-approval studies (Phase 4)Study completedNCT04192487
What this trial is testing

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Who this might be right for
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more
Napo Pharmaceuticals, Inc. 17
Large-scale testing (Phase 3)Active Not RecruitingNCT06550804
What this trial is testing

Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention

Who this might be right for
HIV InfectionsAdherence, Medication
University of Illinois at Chicago 126
Post-approval studies (Phase 4)Study completedNCT03642704
What this trial is testing

HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure

Who this might be right for
Mother to Child HIV Transmission
ANRS, Emerging Infectious Diseases 56
Post-approval studies (Phase 4)Study completedNCT01535235
What this trial is testing

ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study

Who this might be right for
HIV
University of California, San Francisco 31
Next Page